Evidence map›Paper›PMID 37704841›Full record

ArticleCell death and differentiation2023

Correction: The deubiquitinase USP10 regulates KLF4 stability and suppresses lung tumorigenesis.

Xingyun Wang, Shilin Xia, Hongchang Li, Xiang Wang, Chaonan Li, Yulin Chao, Lingqiang Zhang, Chuanchun Han

Open access · bronzeAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death and differentiation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xingyun Wang *Institute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.
Shilin Xia *Clinical Laboratory of Integrative Medicine, The First Affiliated Hospital of Dalian Medical University, Dalian, 116027, China.
Hongchang Li *State Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, 100850, Beijing, China.
Xiang Wang *Institute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.ORCID http://orcid.org/0000-0003-3123-2827
Chaonan LiState Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, 100850, Beijing, China.
Yulin ChaoInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China.
Lingqiang ZhangState Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, 100850, Beijing, China. zhanglq@nic.bmi.ac.cn.
Chuanchun HanInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, 116044, China. hanchuanchun@163.com.
Dalian Medical University · CNBeijing Proteome Research Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37704841
PMCPMC10589221
OpenAlexW4386723055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.